Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,265 public trials 1,195 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

NCT04768075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fujian, Fuzhou, China
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View all 14 locations
View Trial Details
Completed

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

NCT02504489

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Memorial Health Care System Colorado Springs, Colorado, United States
View all 57 locations
View Trial Details
Completed

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

NCT03409614

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Regeneron Research Site Rancho Mirage, California, United States
  • Regeneron Research Site Riverside, California, United States
  • Regeneron Research Site Whittier, California, United States
  • Regeneron Research Site Orange City, Florida, United States
View all 133 locations
View Trial Details
Completed

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

NCT02438722

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Fowler Family Center for Cancer Care Jonesboro, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 638 locations
View Trial Details
Completed

Erlotinib and Docetaxel in Second Line of Treatment in Patients With Non Small Cell Lung Cancer

NCT01350817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Service de Pneumologie, CHU Angers Angers, France
  • Service de pneumologie; Centre Hospitalier d'Annecy Annecy, France
  • Service de Pneumologie; Centre Hospitalier Beauvais, France
  • Service de Pneumologie Beauvais, France
View all 30 locations
View Trial Details
Completed

Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC

NCT04087473

Conditions
ALK-Positive Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • The Chinese University of Hong Kong Hong Kong
  • University Malaya Medical Centre Kuala Lumpur, Malaysia
  • National Cancer Center Singapore Singapore
  • Asan Medical Centre Seoul, South Korea
View Trial Details

Related conditions